Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus

被引：0
|
作者：
Miller, Eden M.
机构：
来源：
JOURNAL OF FAMILY PRACTICE | 2017年 / 66卷 / 02期
关键词：
CARDIOVASCULAR OUTCOMES; POOLED ANALYSIS; SAFETY; EMPAGLIFLOZIN; ROSIGLITAZONE; TOLERABILITY; ASSOCIATION; MANAGEMENT; STATEMENT; EVENTS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S13 / S16
页数：4
相关论文
共 50 条
  • [1] Ertugliflozin: A New Option in the SGLT-2 Inhibitor Market for the Treatment of Type 2 Diabetes Mellitus
    Powell, Jason
    Garland, Scott G.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (05) : 478 - 485
  • [2] Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
    Santos, Leyna Leite
    Camello De Lima, Fernando Jose
    De Sousa-Rodrigues, Celio Fernando
    Barbosa, Fabiano Timbo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 636 - 641
  • [3] Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus
    Atal, Shubham
    Fatima, Zeenat
    Singh, Sakshi
    Balakrishnan, Sadasivam
    Joshi, Rajnish
    DIABETOLOGY INTERNATIONAL, 2021, 12 (03) : 247 - 253
  • [4] Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus
    Shubham Atal
    Zeenat Fatima
    Sakshi Singh
    Sadasivam Balakrishnan
    Rajnish Joshi
    Diabetology International, 2021, 12 : 247 - 253
  • [5] Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor
    Cichocka, Edyta
    Gumprecht, Janusz
    ENDOKRYNOLOGIA POLSKA, 2019, 70 (06) : 522 - 523
  • [6] SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus
    Lukic, Nikola
    Macvanin, Mirjana T.
    Gluvic, Zoran
    Rizzo, Manfredi
    Radak, Djordje
    Suri, Jasjit S.
    Isenovic, Esma R.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (30) : 4781 - 4806
  • [7] Role of the Kidney and SGLT-2 Inhibition in Type 2 Diabetes Mellitus
    Miller, Kevin
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2015, 64 (12): : S54 - S58
  • [8] The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
    Tilinca, Mariana Cornelia
    Tiuca, Robert Aurelian
    Tilea, Ioan
    Varga, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [9] Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus
    Cagliostro, Matthew
    Hundal, Prabhjot
    Ting, Peter
    Patel, Sonika
    Sudarshan, Sangita
    Thomas, Jordan
    Morris, Kathleen
    Mancini, Donna M.
    Moss, Noah
    Lala, Anuradha
    Ravichandran, Ashwin
    Mitter, Sumeet S.
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 18
  • [10] Effect of the SGLT-1 and SGLT-2 Inhibitors Sotagliflozine on the Treatment of Type 1 Diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (06): : 585 - 586
12345